Track: CME Session

Session 9: Basic Science in RCC

Chair(s)

• 

  Gabriel Malouf, MD, PhD

  Institut de Cancérologie de Strasbourg-Europe, Strasbourg University, France

Presentations:

• 10:00 – 10:10 CEST

  Abstract 5: SETD2 loss in kidney cancer - Setting the stage for synthetic lethality
  

  Presenter: Aguirre A. de Cubas, PhD – Medical University of South Carolina
• 10:10 – 10:20 CEST

  Animal Models and Immunotherapy
  

  Speaker: Ian Frew, PhD, BSc – University Medical Center Freiburg
• 10:20 – 10:30 CEST

  Targeting Metabolism in RCC: More Than Just the Cancer Cells
  

  Speaker: Katy Beckermann, PhD, MD – Vanderbilt University Medical Center
• 10:30 – 10:40 CEST

  Modulating the RCC TME to Increase IO Efficacy
  

  Speaker: Charles Drake, MD, PhD – Columbia University Medical Center
• 10:40 – 11:00 CEST

  Panel Question and Answer